-
Loading metrics
The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma
- Ethan Emberley,
- Alison Pan,
- Jason Chen,
- Rosalyn Dang,
- Matt Gross,
- Tony Huang,
- Weiqun Li,
- Andrew MacKinnon,
- Devansh Singh,
- Natalija Sotirovska
x
- Published: November 3, 2021
- https://doi.org/10.1371/journal.pone.0259241